Skip to main content
Top
Published in: International Urology and Nephrology 5/2013

01-10-2013 | Nephrology - Original Paper

Variation of clinical and laboratory features in chronic dialysis patients treated with high-flux hemodialysis after switching to online hemodiafiltration

Authors: Remus Aurel Orasan, Ioan Mihai Patiu, Daniela Anghel, Cezarina Bejan, Ligia Iosub, Camelia Totolici, Mariana Pop, Carmen Turcea, Cristina Teodoru, Olga Hilda Orasan, Ina Maria Kacso, Mirela Gherman Caprioara

Published in: International Urology and Nephrology | Issue 5/2013

Login to get access

Abstract

Purpose

The study of online hemodiafiltration (HDF) benefits over high-flux hemodialysis (HD) raises great interest. The purpose was to compare clinical and laboratory parameters in patients treated with HD who were switched to HDF.

Methods

Forty-eight HD patients (study group) were switched to HDF, while other 521 patients remained on HD as a control group. During last 6 HD months and during first year of HDF, we determined in both groups the following parameters: monthly–weekly dialysis time, systolic and diastolic blood pressure, body mass index (BMI), interdialytic body weight gain (IBWG), blood flow rate (Qb), weekly erythropoietin-stimulating agents dose (EPO), single-pool Kt/V, calcium, phosphorus (P), hemoglobin and normalized protein catabolic ration (nPCR), plus every 3 months—albumin, parathormone (PTH), ferritin and transferrin saturation (TSAT). In both groups, parameters in the last 6 HD months were compared to those in the first 6 months and, respectively, to those in the first year of HDF.

Results

In the study group, albumin and nPCR were significantly higher in the HD period not only compared to the first 6 months of HDF, but also compared to the first year of HDF. IBWG and P were higher with HD compared to the first year of HDF, but not with the first 6 months. PTH, Kt/V, Qb and EPO were higher in both HDF periods. In the control group, albumin was significantly higher in the first 6 months after the switch, but it was significantly lower in the first year. BMI, ferritin, PTH, Kt/V, Qb, TSAT and weekly dialysis time were higher in both HDF periods, while nPCR, EPO, SBP and DBP were lower. IBWG and Hb rose only during the first year after the switch, while P was lower in the first year, but not in the first 6 months.

Conclusions

Nutrition, assessed by albumin, nPCR and BMI, was not improved by HDF compared to HD. With HDF, Kt/V and phosphorus control were better, similar results were observed in the control group. A larger EPO dose was needed with HDF for maintaining a similar hemoglobin level.
Literature
1.
go back to reference Schiffl H (2007) Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 12(1):26–33PubMed Schiffl H (2007) Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 12(1):26–33PubMed
2.
go back to reference Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K (2009) Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol 4(12):1944–1953PubMedCrossRef Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K (2009) Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol 4(12):1944–1953PubMedCrossRef
3.
go back to reference Henderson LW, Beans E (1978) Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int 14:522–525PubMedCrossRef Henderson LW, Beans E (1978) Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int 14:522–525PubMedCrossRef
4.
go back to reference Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, Lévesque R, Nubé MJ, Ter Wee PM, Blankestijn PJ, for the CONTRAST Investigators (2012) Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 23(6):1087–1096PubMedCrossRef Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, Lévesque R, Nubé MJ, Ter Wee PM, Blankestijn PJ, for the CONTRAST Investigators (2012) Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 23(6):1087–1096PubMedCrossRef
7.
go back to reference Locatelli F, Altieri P, Andrulli S, Bolasco P, Sau G, Pedrini LA, Basile C, David S, Feriani M, Montagna G, Di Iorio BR, Memoli B, Cravero R, Battaglia G, Zoccali C (2010) Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol 21(10):1798–1807PubMedCrossRef Locatelli F, Altieri P, Andrulli S, Bolasco P, Sau G, Pedrini LA, Basile C, David S, Feriani M, Montagna G, Di Iorio BR, Memoli B, Cravero R, Battaglia G, Zoccali C (2010) Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol 21(10):1798–1807PubMedCrossRef
8.
go back to reference Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Lévesque R, Nubé MJ, Bots ML, Blankestijn PJ, ter Wee PM, CONTRAST Investigators (2010) Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis 55(1):77–87PubMedCrossRef Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Lévesque R, Nubé MJ, Bots ML, Blankestijn PJ, ter Wee PM, CONTRAST Investigators (2010) Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis 55(1):77–87PubMedCrossRef
9.
go back to reference Bonforte G, Grillo P, Zerbi S, Surian M (2002) Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid. Blood Purif 20(4):357–363PubMedCrossRef Bonforte G, Grillo P, Zerbi S, Surian M (2002) Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid. Blood Purif 20(4):357–363PubMedCrossRef
10.
go back to reference Pinney JH, Oates T, Davenport A (2011) Haemodiafiltration does not reduce the frequency of intradialytic hypotensive episodes when compared to cooled high-flux haemodialysis. Nephron Clin Pract 119(2):c138–c144PubMedCrossRef Pinney JH, Oates T, Davenport A (2011) Haemodiafiltration does not reduce the frequency of intradialytic hypotensive episodes when compared to cooled high-flux haemodialysis. Nephron Clin Pract 119(2):c138–c144PubMedCrossRef
11.
go back to reference Oates T, Pinney JH, Davenport A (2011) Haemodiafiltration versus high-flux haemodialysis: effects on phosphate control and erythropoietin response. Am J Nephrol 33(1):70–75PubMedCrossRef Oates T, Pinney JH, Davenport A (2011) Haemodiafiltration versus high-flux haemodialysis: effects on phosphate control and erythropoietin response. Am J Nephrol 33(1):70–75PubMedCrossRef
12.
go back to reference Stefánsson BV, Abramson M, Nilsson U, Haraldsson B (2012) Hemodiafiltration improves plasma 25-hepcidin levels: a prospective, randomized, blinded, cross-over study comparing hemodialysis and hemodiafiltration. Nephron Extra 2(1):55–65PubMedCrossRef Stefánsson BV, Abramson M, Nilsson U, Haraldsson B (2012) Hemodiafiltration improves plasma 25-hepcidin levels: a prospective, randomized, blinded, cross-over study comparing hemodialysis and hemodiafiltration. Nephron Extra 2(1):55–65PubMedCrossRef
13.
go back to reference Tomo T, Matsuyama K, Nasu M (2004) Effect of hemodiafiltration against radical stress in the course of blood purification. Blood Purif 22(suppl 2):72–77PubMedCrossRef Tomo T, Matsuyama K, Nasu M (2004) Effect of hemodiafiltration against radical stress in the course of blood purification. Blood Purif 22(suppl 2):72–77PubMedCrossRef
14.
go back to reference Combarnous F, Tetta C, Cellier CC, Wratten ML, Custaud MA, De Catheu T, Fouque D, David S, Carraro G, Laville M (2002) Albumin loss in on-line hemodiafiltration. Int J Artif Organs 25(3):203–209PubMed Combarnous F, Tetta C, Cellier CC, Wratten ML, Custaud MA, De Catheu T, Fouque D, David S, Carraro G, Laville M (2002) Albumin loss in on-line hemodiafiltration. Int J Artif Organs 25(3):203–209PubMed
15.
go back to reference Cross J, Davenport A (2011) Does online hemodiafiltration lead to reduction in trace elements and vitamins? Hemodial Int 15(4):509–514PubMedCrossRef Cross J, Davenport A (2011) Does online hemodiafiltration lead to reduction in trace elements and vitamins? Hemodial Int 15(4):509–514PubMedCrossRef
16.
go back to reference Altieri P, Sorba G, Bolasco P, Ledebo I, Ganadu M, Ferrara R, Menneas A, Asproni E, Casu D, Passaghe M, Sau G, Cadinu F, Sardinian Study Group on Hemofiltration On-line (2004) Comparison between hemofiltration and hemodiafiltration in a long-term prospective cross-over study. J Nephrol 17(3):414–422PubMed Altieri P, Sorba G, Bolasco P, Ledebo I, Ganadu M, Ferrara R, Menneas A, Asproni E, Casu D, Passaghe M, Sau G, Cadinu F, Sardinian Study Group on Hemofiltration On-line (2004) Comparison between hemofiltration and hemodiafiltration in a long-term prospective cross-over study. J Nephrol 17(3):414–422PubMed
17.
go back to reference Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W (2000) A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11(12):2344–2350PubMed Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W (2000) A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11(12):2344–2350PubMed
18.
go back to reference Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J (2006) On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 24(2):163–173PubMedCrossRef Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J (2006) On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 24(2):163–173PubMedCrossRef
19.
go back to reference Zehnder C, Gutzwiller JP, Renggli K (1999) Hemodiafiltration—a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 52(3):152–159PubMed Zehnder C, Gutzwiller JP, Renggli K (1999) Hemodiafiltration—a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 52(3):152–159PubMed
21.
go back to reference Movilli E, Camerini C, Gaggia P, Poiatti P, Pola A, Viola BF, Zubani R, Jeannin G, Cancarini G (2011) Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. Nephrol Dial Transpl 26(12):4032–4037CrossRef Movilli E, Camerini C, Gaggia P, Poiatti P, Pola A, Viola BF, Zubani R, Jeannin G, Cancarini G (2011) Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. Nephrol Dial Transpl 26(12):4032–4037CrossRef
22.
go back to reference Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J (2006) On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 24:163–173PubMedCrossRef Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J (2006) On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 24:163–173PubMedCrossRef
23.
go back to reference Lin CL, Huang CC, Yu CC, Wu CH, Chang CT, Hsu HH, Hsu PY, Yang CW (2002) Improved iron utilization and reduced erythropoietin resistance by on-line hemodiafiltration. Blood Purif 20:349–356PubMedCrossRef Lin CL, Huang CC, Yu CC, Wu CH, Chang CT, Hsu HH, Hsu PY, Yang CW (2002) Improved iron utilization and reduced erythropoietin resistance by on-line hemodiafiltration. Blood Purif 20:349–356PubMedCrossRef
24.
go back to reference Pedrini LA, De Cristofaro V, Comelli M, Casino FG, Prencipe M, Baroni A, Campolo G, Manzoni C, Colì L, Ruggiero P, Acquistapace I, Auriemma L (2011) Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transpl 26(8):2617–2624CrossRef Pedrini LA, De Cristofaro V, Comelli M, Casino FG, Prencipe M, Baroni A, Campolo G, Manzoni C, Colì L, Ruggiero P, Acquistapace I, Auriemma L (2011) Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transpl 26(8):2617–2624CrossRef
25.
go back to reference Meert N, Waterloos MA, Van Landschoot M, Dhondt A, Ledebo I, Glorieux G, Goeman J, Van der Eycken J, Vanholder R (2010) Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. Artif Organs 34(7):580–585PubMedCrossRef Meert N, Waterloos MA, Van Landschoot M, Dhondt A, Ledebo I, Glorieux G, Goeman J, Van der Eycken J, Vanholder R (2010) Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. Artif Organs 34(7):580–585PubMedCrossRef
Metadata
Title
Variation of clinical and laboratory features in chronic dialysis patients treated with high-flux hemodialysis after switching to online hemodiafiltration
Authors
Remus Aurel Orasan
Ioan Mihai Patiu
Daniela Anghel
Cezarina Bejan
Ligia Iosub
Camelia Totolici
Mariana Pop
Carmen Turcea
Cristina Teodoru
Olga Hilda Orasan
Ina Maria Kacso
Mirela Gherman Caprioara
Publication date
01-10-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 5/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0341-7

Other articles of this Issue 5/2013

International Urology and Nephrology 5/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.